Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

Vitara RX vs Navio MD

Two GLP-1 deals, scored on the same six factors. Vitara RX lands a Value Score of 91, Navio MD a 75. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

Vitara RX

#4 · Grade A · Best Value

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full Vitara RX review →
VS

Navio MD

#133 · Grade C+ · Fair Price

Est. first month

From $189/mo (starting dose, compounded)

Save ~86% vs brand-name
Get this deal Full Navio MD review →

The verdict

Better value: Vitara RX

Vitara RX takes it on Value Score, 91 to 75 an est. $99/mo first month, with no teaser step-up baked in. Navio MD isn't out of it: Shoppers who want compounded tirzepatide with brand-name fallback across 48 states.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealVitara RXNavio MD
Value Score91 (A)75 (C+)
Est. first month$99/moFrom $189/mo (starting dose, compounded)
Save vs brand-name~93%~86%
Semaglutide$99/moFrom $345/mo (starting dose, brand-name)
Tirzepatide$149/moFrom $189/mo (starting dose, compounded)
Both moleculesYesYes
PricingFlat — no step-upWatch
Coverage49 states48 states

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

96
Lowest Real Price
74
Vitara RX: 96. Navio MD: 74.
90
No Teaser-Rate Bait
64
Vitara RX: 90. Navio MD: 64.
88
Nationwide Availability
88
Vitara RX: 88. Navio MD: 88.
92
Both Molecules
92
Vitara RX: 92. Navio MD: 92.
95
Easy Cancellation
58
Vitara RX: 95. Navio MD: 58.
67
Reputation
82
Vitara RX: 67. Navio MD: 82.

Vitara RX

VitaraRx is a direct-to-consumer telehealth marketplace offering compounded semaglutide and tirzepatide at flat per-drug pricing across all doses — no membership or hidden fees.

Why it's a deal

  • Among the lowest flat pricing in the market — $99/mo semaglutide and $149/mo tirzepatide, all doses same price
  • Names its 503A pharmacy partner (Manifest Pharmacy, Greer SC) — strong supply-chain transparency
  • LegitScript Certified
  • Publishes the FDA compounded-medication disclaimer
  • Covers 49 states with an explicit state list, not vague "most states" language

The fine print

  • No corporate legal entity disclosed — only the trade name "VitaraRx"
  • No named medical director — all clinical decisions made by independent providers (marketplace model)
  • All sales final — no medication returns
  • Per-vial mg quantity isn't clearly disclosed, making price comparisons harder
  • Doesn't ship to Alaska

Navio MD

NavioMD offers compounded tirzepatide ($247/mo) plus brand-name Ozempic ($1,199/mo) and Mounjaro ($1,249/mo).

Why it's a deal

  • LegitScript verified with board-certified providers and US-licensed pharmacies
  • Both compounded and brand-name options
  • 48-state coverage
  • Hours 9am–10pm EST Mon–Sun
  • Transparent tiered pricing: you only pay for your current dose

The fine print

  • Not available in Alabama and Mississippi
  • Compounded option is tirzepatide only — no compounded semaglutide listed
  • Also offers women's HRT (broader platform)
  • Pricing is tiered by dose ('as low as'); the entry prices climb as your dose increases
Get the Vitara RX deal Get the Navio MD deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores Vitara RX is ranked on the Vitara RX alternatives board, and the same list for the other side is on alternatives to Navio MD.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.